arrow
R

Rayyan Hemetsberger

Medical University of Vienna
H指数:18
被引数:1,273

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-World Threshold-Based Eligibility for Emerging Lipoprotein(a)-Targeted Therapies in Chronic and Acute Coronary Syndrome

基于真实世界阈值的脂蛋白(a)靶向疗法在慢性与急性冠状动脉综合征中的适用性

2026-09-250
PRE
Biodegradable polymer sirolimus-eluting or durable polymer zotarolimus-eluting stents in high bleeding-risk patients with acute coronary syndrome: the BIOFLOW-DAPT randomized trial

在急性冠脉综合征高风险出血患者中使用可降解聚合物西罗莫司洗脱支架或持久聚合物卓他莫司洗脱支架:BIOFLOW-DAPT随机试验

2026-08-050
PRE
Drug-Coated Balloon Versus Drug-Eluting Stent for De Novo Lesions of Large Coronary Arteries: A Systematic Review and Meta-Analysis of Angiographic and Clinical Outcomes

Hassan, A.; Mansour, A.; Elkasaby, M.H.; Ramadan, S.; Nabil, A.; Suwannasom, P.; Saad, M.; de Winter, R.J.; Hemetsberger, R.; Abdelghani, M. 药物涂层球囊与药物洗脱支架治疗大冠状动脉原发病灶:一项关于血管造影和临床结局的系统评价与Meta分析。Catheter. Cardiovasc. Interv. 2025; ahead of print. [Google Scholar] [CrossRef]

2025-10-011
PRE
In-hospital Outcomes of Rotational Atherectomy in ST-Elevation Myocardial Infarction: Results From the Multicentre ROTA-STEMI Network

ST段抬高型心肌梗死旋磨术的院内预后: 来自多中心ROTA-STEMI网络的结果

2024-07-012
OAAI
Incidence and pattern of urgent revascularization in acute coronary syndromes treated with ticagrelor or prasugrel
2024-05-130
OAAI